Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yifei Moxibustion for Immune Function in COPD
NCT07131020Recruiting
- Sponsor
- Henan University of Chinese Medicine
- Start
- May 2024
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (3 arms), sponsored by Henan University of Chinese Medicine. Primary endpoints: Plasma exosomal miR-125b level at 3 months, T-cell subsets at 3 months and 1 more. Started May 2024; status: recruiting.
Beyond the preview
Go deeper on NCT07131020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07131020.